Background Image
Previous Page  145 / 156 Next Page
Information
Show Menu
Previous Page 145 / 156 Next Page
Page Background

143

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

244

Pace MC, Passavanti MB, Grella E, Mazzariello L, Maisto M, Barbarisi M, Baccari E, San-

sone P, Aurilio C.Buprenorphine in long-term control of chronic pain in cancer patients.

Front Biosci 2007; 12: 1291-1299.)

245

Paice JA, Von Roenn JH, Hudgins JC, Luong L, Krejcie TC, Avram MJ. Morphine bioavaila-

bility from a topical gel formulation in volunteers. J Pain Symptom Manage 2008; 35(3):

314-320.

246

Paiva CS, Andreoni C, Cunha GP, Khalil W, Ortiz V. Differences among patients undergoing

perineal or retropubic radical prostatectomy in pain and perioperative variables: a pros-

pective study. BJU Int 2009; 104(9): 1219-1226.

247

Pan H, Zhang Z, Zhang Y, Xu N, Lu L, Dou C, Guo Y, Wu S, Yue J, Wu D, Dai Y. Efficacy and

tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe

cancer pain. Clin Drug Investig 2007; 27(4): 259-267.

248

Pandazi A, Kapota E, Matsota P, Paraskevopoulou P, Dervenis C, Kostopanagiotou G.

Preincisional versus postincisional administration of parecoxib in colorectal surgery:

effect on postoperative pain control and cytokine response. A randomized clinical trial.

World J Surg 2010; 34(10): 2463-2469.

249

Paparella S, Finkelberg E, Varisco D, Tondelli E, Rocco F. Use of zoledronic acid in patients

with prostate cancer bone metastases: control of pain and musculoskeletal complica-

tions. Urologia 2011; Dec 2:0.

250

Papatheofanis FJ, Smith C, Najib M. Improvement in sensory pain rating after palliative

systemic radionuclide therapy in patients with advanced prostate cancer. Am J Ther 2009;

16(2): 127-132.

251

Park MJ, Kim YS, Rhim H, Lim HK, Shin BS, Choi D, Lee MW, Kim DH. Prospective analysis

of the pattern and risk for severe vital sign changes during percutaneous radiofrequency

ablation of the liver under opioid analgesia. AJR Am J Roentgenol 2010; 194(3): 799-808.

252

Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors

in medically ill patients with and without histories of substance abuse. Clin J Pain 2006;

22(2): 173-181.

253

Patarica-Huber E, Boskov N, Pjevic M. Multimodal approach to therapy-related neuropa-

thic pain in breast cancer. J BUON 2011; 16(1): 40-45.

254

Pendleton J, Costa J, Wludyka P, Carvin DM, Rosser CJ. Combination of oral tramadol,

acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control

during transrectal ultrasound guided biopsy of the prostate: a prospective, randomized,

controlled trial. J Urol 2006; 176(4 Pt 1): 1372-1375.

255

Plantevin F, Pascal J, Morel J, Roussier M, Charier D, Prades JM, Auboyer C, Molliex S.

Effect of mandibular nerve block on postoperative analgesia in patients undergoing

oropharyngeal carcinoma surgery under general anaesthesia. Br J Anaesth 2007; 99(5):

708-712.

256

Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Breakthrough pain in community-

dwelling patients with cancer pain and noncancer pain, part 2: impact on function,

mood, and quality of life. J Opioid Manag 2010; 6(2): 109-116.

Literaturverzeichnis